Miraean Pharmaceutical, formerly known as One Asia Pacific Medical, was established in June 2018. In June 2019, the company secured exclusivity in the Philippines for "Jadaerofil," an erectile dysfunction treatment, and later that year, hosted "Good Friends in Manila 2019," a charity event featuring Momoland, Kim Jae-hwan, and Ha Sungyoon of Produce 101 to support underprivileged children. By early 2020, the company expanded its research and development efforts with the Eagle 25 product line, including Ginseng Multi-Gel, Ringer Solution, and Lacto Solution. It also secured exclusivity for "Dr. Clo," a 99.9% sterilization and deodorization product, and established DYD, a subsidiary in Korea specializing in medical equipment manufacturing. In mid-2020, Miraean Pharmaceutical secured exclusivity for "Durok," a specialized drug for rheumatoid arthritis and malaria prevention, and exported 10 million KF94 masks to Singapore. Additionally, the company partnered with Korea National University Hospital to supply medical equipment, hospital management systems, and advanced medical technology to Cambodia General Hospital. In May 2022, it expanded its portfolio by manufacturing Soonox (botox) through OEM production in Korea. In January 2023, the company officially rebranded as Miraean Pharmaceutical, reflecting its commitment to pharmaceutical innovation. Most recently, in March 2024, it successfully launched the Eagle 25 brand and its products—Ginseng Multi-Gel, Lacto Solution, Ringer Solution, and Soonox—at Shangri-La, The Fort, marking a significant milestone in its growth and expansion.